Hepion Pharmaceuticals, Inc. (HEPA) News
Follow Hepion Pharmaceuticals, Inc. (HEPA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Hepion Pharmaceuticals acquires Gravitas Life Sciences for $2M cash
Hepion Pharmaceuticals completed the acquisition of Gravitas Life Sciences under a Membership Interest Purchase Agreement, paying $2.0 million in cash, issuing 25 million shares subject to a 19.99% issuance cap, and payi
EQUITY | Oct 09, 2026, 08:33 PM UTC
M
Hepion Pharmaceuticals raises $500,000 via 8% secured convertible note
Hepion Pharmaceuticals entered into a financing with Gravitas Capital, issuing a $500,000 secured convertible note and a warrant for 12,500,000 shares. The note carries 8% PIK interest and matures Sep 3, 2027.
EQUITY | Sep 08, 2026, 09:34 PM UTC
L
Hepion raises $400,000 via private placement; warrants issued
Hepion raised $400,000 in a private placement at $0.05 and issued five-year warrants exercisable at $0.06.
EQUITY | Aug 27, 2026, 08:35 PM UTC